News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,742 Results
Type
Article (25924)
Company Profile (59)
Press Release (355759)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104271)
Career Advice (449)
Deals (16874)
Drug Delivery (51)
Drug Development (47594)
Employer Resources (47)
FDA (12262)
Job Trends (8441)
News (185938)
Policy (19424)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (26750)
ALS (57)
Alzheimer's disease (811)
Antibody-drug conjugate (ADC) (51)
Approvals (12326)
Artificial intelligence (170)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (192)
Cancer (1431)
Cardiovascular disease (119)
Career advice (407)
Career pathing (13)
CAR-T (70)
Cell therapy (199)
Cervical cancer (13)
Clinical research (40513)
Collaboration (439)
Compensation (126)
Complete response letters (9)
COVID-19 (1493)
CRISPR (12)
C-suite (139)
Cystic fibrosis (42)
Data (1525)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (174)
Diagnostics (3521)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (36917)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (51807)
Executive appointments (447)
FDA (13250)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (402)
Gene editing (36)
Generative AI (10)
Gene therapy (126)
GLP-1 (402)
Government (3035)
Grass and pollen (3)
Guidances (42)
Healthcare (12187)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (19)
Infectious disease (1563)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (50)
Interviews (40)
IPO (7038)
IRA (19)
Job creations (1839)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (169)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (232)
Lymphoma (100)
Machine learning (3)
Management (17)
Manufacturing (104)
MASH (48)
Medical device (12906)
Medtech (12909)
Mergers & acquisitions (10125)
Metabolic disorders (432)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1144)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (16)
Obesity (218)
Opinion (70)
Ovarian cancer (52)
Pain (64)
Pancreatic cancer (53)
Parkinson's disease (88)
Partnered (11)
Patents (112)
Patient recruitment (82)
Peanut (37)
People (34720)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11605)
Phase II (17533)
Phase III (14414)
Pipeline (686)
Policy (59)
Postmarket research (1668)
Preclinical (3615)
Press Release (18)
Prostate cancer (76)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (184)
Real estate (2847)
Recruiting (16)
Regulatory (14212)
Reports (16)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (51)
Series A (66)
Series B (48)
Service/supplier (3)
Sickle cell disease (21)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2120)
Stomach cancer (8)
Supply chain (38)
Tariffs (11)
The Weekly (8)
Vaccines (354)
Venture capitalists (13)
Weight loss (141)
Women's health (17)
Worklife (4)
Date
Last 7 days (457)
Last 30 days (1332)
Last 365 days (18379)
2025 (5902)
2024 (19849)
2023 (22737)
2022 (30681)
2021 (32990)
2020 (32191)
2019 (28414)
2018 (21810)
2017 (18909)
2016 (18115)
2015 (21197)
2014 (16027)
2013 (13244)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (118)
Arkansas (10)
Asia (24550)
Australia (3887)
California (3052)
Canada (1221)
China (372)
Colorado (165)
Connecticut (172)
Delaware (115)
Europe (47936)
Florida (543)
Georgia (127)
Idaho (33)
Illinois (359)
India (14)
Indiana (223)
Iowa (3)
Japan (119)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (634)
Massachusetts (2134)
Michigan (107)
Minnesota (270)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1125)
New Mexico (9)
New York (953)
North Carolina (554)
North Dakota (4)
Northern California (1334)
Ohio (131)
Oklahoma (3)
Oregon (23)
Pennsylvania (825)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (21)
Southern California (1171)
Tennessee (77)
Texas (538)
United States (12775)
Utah (111)
Virginia (80)
Washington D.C. (40)
Washington State (229)
West Virginia (3)
Wisconsin (42)
381,742 Results for "baylis medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Baylis Medical Technologies Introduces the PowerWire® Pulse Radiofrequency (RF) Guidewire, Designed to Create a Path Through Soft Tissues
October 1, 2024
·
2 min read
Business
Baylis Medical Technologies Signs Distribution Agreement with Oscor
Baylis Medical Technologies Inc. is pleased to announce it is assuming responsibility for the sales and distribution of the Steerable and Guiding Sheaths currently sold direct-to-hospital by Oscor in the United States.
November 1, 2022
·
3 min read
Deals
Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc.
February 15, 2022
·
4 min read
Deals
Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion
October 6, 2021
·
6 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Baylis Medical Announces First Clinical Case Using the VersaCross® Large Access Solution in Canada
Baylis Medical announced the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure procedure.
August 25, 2021
·
3 min read
Baylis Medical Announces First Clinical Use of the VersaCross® Large Access Solution to Deliver Large Bore Therapy Solutions
Baylis Medical announced the first clinical use of the VersaCross® Large Access Solution.
July 29, 2021
·
3 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Baylis Medical Named a Gold Standard Winner of the Canada’s Best Managed Companies Award
Baylis Medical is proud to announce that it is a Gold Standard Winner of the Canada’s Best Managed Companies award.
May 5, 2021
·
2 min read
Mentice receives order of total SEK 5.9 million from Baylis Medical Company
Mentice AB a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement with Baylis Medical Company to provide simulation solutions.
June 30, 2021
·
2 min read
1 of 38,175
Next
